Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B7c12c1702ee040f4c2011b0f62a06903> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B7c12c1702ee040f4c2011b0f62a06903 NCIT_P378 "NCI" @default.
- B7c12c1702ee040f4c2011b0f62a06903 type Axiom @default.
- B7c12c1702ee040f4c2011b0f62a06903 annotatedProperty IAO_0000115 @default.
- B7c12c1702ee040f4c2011b0f62a06903 annotatedSource NCIT_C171872 @default.
- B7c12c1702ee040f4c2011b0f62a06903 annotatedTarget "An orally bioavailable, peptidomimetic inhibitor of hepatitis C virus (HCV) NS3/4A protease, with antiviral activity against HCV and potential antiviral activity against SARS-CoV-2. Upon oral administration, danoprevir binds to and blocks the activity of HCV NS3/4A protease. This prevents the cleavage and processing of HCV viral proteins leading to the inhibition of HCV replication. Danoprevir may also bind to and block of the activity of SARS-CoV-2 protease. This prevents the cleavage and processing of SARS-CoV-2 viral proteins leading to the inhibition of SARS-CoV-2 replication. NS3/4A, a chymotrypsin-like serine protease, is responsible for cleavage at four sites of the HCV polyprotein to form the viral proteins required for HCV replication. It plays a key role in the HCV viral replication process. HCV infection is associated with the development of hepatocellular carcinoma (HCC). A chymotrypsin-like protease is responsible for cleavage of the SARS-CoV-2 viral polyprotein to form the RNA replicase-transcriptase complex, which plays a key role in the SARS-CoV-2 viral transcription and replication process." @default.